Product Code: ETC7182613 | Publication Date: Sep 2024 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Parkinsons Disease Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Parkinsons Disease Market - Industry Life Cycle |
3.4 Fiji Parkinsons Disease Market - Porter's Five Forces |
3.5 Fiji Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Fiji Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Fiji Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Fiji Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Fiji Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Fiji Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Parkinsons Disease Market Trends |
6 Fiji Parkinsons Disease Market, By Types |
6.1 Fiji Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Fiji Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Fiji Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Fiji Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Fiji Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Fiji Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Fiji Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Fiji Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Fiji Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Fiji Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Fiji Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Fiji Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Fiji Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Fiji Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Fiji Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Fiji Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Fiji Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Fiji Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Fiji Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Fiji Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Fiji Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Fiji Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Fiji Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Fiji Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Fiji Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Fiji Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Fiji Parkinsons Disease Market Export to Major Countries |
7.2 Fiji Parkinsons Disease Market Imports from Major Countries |
8 Fiji Parkinsons Disease Market Key Performance Indicators |
9 Fiji Parkinsons Disease Market - Opportunity Assessment |
9.1 Fiji Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Fiji Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Fiji Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Fiji Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Fiji Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Fiji Parkinsons Disease Market - Competitive Landscape |
10.1 Fiji Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Fiji Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |